Applications of Radioisotopes in Cancer Treatment
Did you know in 2022, there were an estimated 20 million new cancer cases and about 9 million cancer-related deaths globally? What’s more staggering is cancer is one of the leading causes of death worldwide and by 2040, the number of new cancer cases annually is forecasted to rise to 29.9 million! Despite being such a fatal condition for humankind, the treatment of cancer is still a dilemma. When you think about cutting-edge treatments for cancer, all we can imagine is complex procedures or advanced technology. However, only a few people know about medical radioisotopes because although they are effective, their production has been a challenge.
Medical radioisotopes are tiny but powerful elements
that play a substantial role in the fight against cancer. How? Well, here’s a
guide on how these medical marvels work and what their transformative impact on
cancer treatment is.
What
are Medical Radioisotopes?
Medical radioisotopes are radioactive isotopes used
in diagnostic imaging and therapy. Their ability to emit radiation makes them
invaluable in pinpointing and treating cancer cells or oncogenic cells. These
isotopes are carefully packed based on their properties, such as half-life and
type of radiation emitted, so healthcare professionals can target cancerous
tissues precisely without damaging any healthy cells.
Lutetium-177:
A Game Changer in Therapy
Lutetium 177 production has revolutionized targeted cancer therapy. The isotope is used
in therapies like peptide receptor radionuclide therapy (PRRT), where it is
attached to a molecule that binds specifically to cancer cells and delivers
targeted radiation directly to the cancerous cells.
The beta radiation emitted by this isotope is
perfect for this cause because it penetrates tissues just enough to destroy the
tumor without excessively harming any surrounding tissues that might be
healthy.
Actinium-225
Ac-225 is another promising
radioisotope used in cancer treatment, part of a newer class of targeted alpha
therapy agents. Unlike beta radiation, Ac-225 emits alpha particles, which have
a higher energy and a shorter range. This is beneficial for targeting small
clusters of cancer cells or even individual cells that might be resistant to
other forms of radiation.
Challenges
in Producing Radioisotopes
Yes, medical isotopes can save lives, but their
production process is no cakewalk because it requires specialized facilities
and complex technology, which is expensive and time-consuming. Besides, the
production of these isotopes requires a consistent and reliable supply, which
is tough due to the short half-lives of the isotopes and limited production
sites. Stringent regulations and quality control are not easy either and the
high production costs can also limit the accessibility and affordability for clinicians,
researchers, as well as healthcare giants.

Comments
Post a Comment